CVS Health Corp (NY:CVS)

86.46 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

72 73 Next >

Which S&P500 stocks are the most active on Wednesday? ↗

February 12, 2025

Stay informed about the most active stocks in the S&P500 index on Wednesday's session. Discover the stocks that are generating the highest trading volume and driving market activity.

Via Chartmill

Nasdaq Edges Higher; CVS Health Shares Jump Following Upbeat Earnings ↗

February 12, 2025

Via Benzinga

Why CVS Health (CVS) Stock Is Trading Up Today

February 12, 2025

Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 16.4% in the morning session after the company reported strong fourth-quarter results that exceeded expectations, with same-store...

Via StockStory

These S&P500 stocks are moving in today's session ↗

February 12, 2025

Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

Market Whales and Their Recent Bets on CVS Options ↗

February 12, 2025

Via Benzinga

Why CVS Health Stock Popped Today ↗

February 12, 2025

Via The Motley Fool

Earnings Scheduled For February 12, 2025 ↗

February 12, 2025

Via Benzinga

Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday? ↗

February 12, 2025

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New...

Via Benzinga

Topics Economy

CVS Health (CVS) Q4 2024 Earnings Call Transcript ↗

February 12, 2025

CVS earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Crude Oil Down Over 2%; Upstart Shares Jump Following Earnings ↗

February 12, 2025

Via Benzinga

What's a Fair Price for CVS Stock? ↗

February 11, 2025

Via The Motley Fool

Peering Into CVS Health's Recent Short Interest ↗

February 10, 2025

Via Benzinga

Is CVS Health's Dividend Safe? ↗

February 07, 2025

Via The Motley Fool

This House of Representative Just Sold Up To $50K In CVS Health Stock ↗

February 05, 2025

Via Benzinga

CVS Beats EPS Estimates, Losses Loom ↗

February 12, 2025

CVS Health reported mixed fourth-quarter earnings, beating estimates but showing challenges in key areas.

Via The Motley Fool

Gilead Sciences, Upstart, Mercury General, Confluent And Other Big Stocks Moving Higher On Wednesday ↗

February 12, 2025

Via Benzinga

Discover the top S&P500 movers in Wednesday's pre-market session. ↗

February 12, 2025

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

CVS Health Q4 Earnings: Revenue And EPS Beat, Same-store Prescription Volume Up 5.9%, Upbeat FY25 Outlook And More ↗

February 12, 2025

CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance set at $5.75-$6.00.

Via Benzinga

CVS Health Surges Premarket As Q4 Earnings Blow Past Estimates, Retail Buzz Builds ↗

February 12, 2025

The company said it continues to see growth in Pharmacy and Consumer Wellness while working to address challenges in its Health Care Benefits segment.

Via Stocktwits

CVS Health’s (NYSE:CVS) Q4 Sales Top Estimates, Stock Soars

February 12, 2025

Diversified healthcare company CVS Health (NYSE:CVS) announced better-than-expected revenue in Q4 CY2024, with sales up 4.2% year on year to $97.71 billion. Its non-GAAP profit of $1.19 per share was...

Via StockStory

Topics Artificial Intelligence Economy Fraud

US Stocks Set For A Cautious Start Ahead Of Inflation Data: Expert Says 'Strong Bull Markets Tend To Roar Back To Life After Corrections' ↗

February 12, 2025

U.S. stock futures fell on Wednesday after a mixed close on Tuesday as Federal Reserve Chairman Jerome Powell Congress testimony.

Via Benzinga

Topics Economy

Dow Gains Over 100 Points Following Powell Comments: Fear & Greed Index Remains In 'Neutral' Zone ↗

February 12, 2025

Via Benzinga

Topics Stocks

CVS Health, Kraft Heinz And 3 Stocks To Watch Heading Into Wednesday ↗

February 12, 2025

Via Benzinga

CVS Health Stock Is Relatively Cheap, Analyst Highlights Cost Trend Pressure Ahead Of Q4 Earnings ↗

February 11, 2025

CVS Health reports Q4 earnings on Feb. 12, with analysts watching cost trends, Medicare Advantage enrollment, and medical loss ratio impacts.

Via Benzinga

CVS Stock Approaches Q4 Earnings With Resistance In Sight ↗

February 11, 2025

CVS Health (CVS) reports Q4 earnings on Wed. Stock is down 29.78% in past yr, up 22.72% YTD. Bullish trend but mixed signals. Analysts rate it a Buy with avg price tgt $63.67, potential 17.01% upside....

Via Benzinga

CVS Health (CVS) Q4 Earnings Report Preview: What To Look For

February 11, 2025

Diversified healthcare company CVS Health (NYSE:CVS) will be announcing earnings results tomorrow morning. Here’s what investors should know.

Via StockStory

Billionaire Money Managers Are Piling Into 3 High-Yield Dividend Stocks Amid a Historically Pricey Stock Market ↗

February 05, 2025

Value-focused billionaire asset managers are trading out pricey stocks for perceived-to-be safe, income-producing, brand-name businesses.

Via The Motley Fool

Cigna Misses EPS: What It Means for the Health Insurance Industry

February 04, 2025

Cigna is one of the most efficiently managed health insurance companies evidenced by its foresight to sell its Medicare Advantage business before the fallout.

Via MarketBeat

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields ↗

February 04, 2025

Via Benzinga

Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now

February 03, 2025

Teva Pharmaceuticals is the world's largest generic drug maker with over 500 generics in its portfolio, but shares sold off on its recent earnings, buying opp?

Via MarketBeat

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.